RecruitingNCT04878666

Prospective Assessment of Quality of Life in Patients With Locally Recurrent Breast Cancer and Hyperthermic Radiotherapy

Prospektive Erfassung Der Lebensqualität Bei Patientinnen Mit Lokal Rezidiviertem Mammakarzinom Und Hyperthermer Radiotherapie (UKT HT03.1)


Sponsor

University Hospital Tuebingen

Enrollment

20 participants

Start Date

Aug 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Prospective assessment of Quality of Life in patients with locally recurrent breast cancer after close R0, R1 or R2 resection or local inoperability and hyperthermic radiotherapy.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria5

  • Histologically confirmed local recurrence of breast cancer after close resection (≤1mm Resection margin), R1 or R2 resection respectively inoperable recurrence of the chest wall
  • age ≥18 Jahre
  • ECOG PS 0-2
  • Estimated life expectancy more than 2 years
  • Informed consent

Exclusion Criteria10

  • Extensive distant metastases that have an estimated life expectancy of \<2a
  • Heart disease: severe heart failure (NHYA III / IV), coronary heart disease, state after Myocardial infarction within the last 6 months), AV block III °
  • Cardiac pacemaker
  • Second malignancy (except cervical carcinomas in situ, local controlled basaliomas, superficial bladder carcinomas (Ta, Tis, T1) or other carcinomas that have lasted more than 5 years behind and have been treated curatively)
  • Pregnancy or breastfeeding
  • Subclavian vein thrombosis less than \<6 months behind
  • Other circumstances that preclude hyperthermia
  • Circumstances that conflict with regular follow-up care
  • Transplanted organs
  • Other implants of the ipsilateral chest wall

Locations(1)

University Hospital Tübingen, Department of Radiation Oncology

Tübingen, Baden-Wurttemberg, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04878666


Related Trials